LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework

    21/09/2022
    PRESS RELEASE

    Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework

    Brussels, 21 September 2022 – EuropaBio is pleased to announce that Freget Glaser & Associés has joined as an associate member. A law firm based in Paris, focusing on EU competition, regulatory and public economic law, Fréget Glaser has been advising pharmaceutical and innovative companies for more than 20 years.

    Adding to their legal expertise a deep knowledge of the regulated sectors, the firm supports its clients in the definition and implementation of their legal strategy and represents them before the French courts, competition and sector regulatory authorities, as well as before the European Commission and Court of Justice.

    EuropaBio Director-General Dr. Claire Skentelbery commented “We are thrilled to have a law firm among our members, and we are confident that Freget Glaser’s expertise in legal and regulatory strategy can bring an added value to the association”.

    Olivier Fréget, Founding Partner of Freget Glaser & Associés, added: “We have seen the life sciences sector evolve around the major technological and scientific developments, particularly in biotech. These have raised numerous regulatory challenges that continue to stimulate the debate. We look forward to contributing to these thought exchanges from our legal perspective”.

    Freget Glaser & Associés joins EuropaBio


    Download
    2022_09_G_PR_Freget-Glaser-joins-EuropaBioDownload
    Share
    Communications Team
    Communications Team

    Related posts

    06/02/2026

    OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States


    Read more
    03/02/2026

    Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe


    Read more
    29/01/2026

    EuropaBio Consultation Response: Public Procurement Directives


    Read more

    Important links

    • OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States
    • Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.